Bayer AG
- A Study Is Retracted, Renewing Concerns About the Weedkiller Roundup - Problems with a 25-year-old landmark paper on the safety of Roundup’s active ingredient, glyphosate, have led to calls for the E.P.A. to reassess the widely used chemical.
- This is how exposed European Big Pharma is to the U.S. - U.S. pricing has been the bigegts issue of the year for drugmakers heavily exposed to the U.S. market.